[PREVENTION OF HYPERACTIVE ERYTHROPOIESIS AS A THERAPEUTIC CRITERION IN THALASSEMIA AND OTHER CORPUSCULAR ANEMIAS. PRELIMINARY NOTE].
D000740:Anemia; D001803:Blood Transfusion; D003676:Deferoxamine; D004920:Erythropoiesis; D006801:Humans; D006877:Hydroxamic Acids; D007223:Infant; D013163:Splenomegaly; D013789:Thalassemia
D006877:Hydroxamic Acids; D003676:Deferoxamine
BLOOD TRANSFUSION; DEFEROXAMINE; ERYTHROPOIESIS; HYDROXAMIC ACID; INFANT; SPLENOMEGALY; THALASSEMIA